SCHEMBL25848182

SCHEMBL25848182

C=C(C)C(=O)OCC(C)(C)COc1ccc2cc(-c3ccc(CCCCC)cc3CC)c(=O)oc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.40
MAOA P21397 2/20 0.40
NPC1 O15118 7/20 0.39
RAB9A P51151 7/20 0.39
KDM4E B2RXH2 6/20 0.38
HPGD P15428 5/20 0.38
GLA P06280 4/20 0.38
ALDH1A1 P00352 4/20 0.38
GAA P10253 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 2/20 0.38
MAPK1 P28482 2/20 0.38
PKM P14618 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SLC10A1 Q14973 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PTPN7 P35236 1/20 0.36
HSD17B10 Q99714 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25848183 0.92 MAOB (0.40) MAOBMAOANPC1RAB9AKDM4E
SCHEMBL22625088 0.91 MAOB (0.38) MAOBMAOANPC1RAB9AKDM4E
SCHEMBL25848191 0.91 NPC1 (0.42) MAOBMAOANPC1RAB9AKDM4E
SCHEMBL22624948 0.90 MAOB (0.38) MAOBMAOANPC1RAB9AKDM4E
SCHEMBL22624916 0.90 MAOB (0.37) MAOBMAOANPC1RAB9AKDM4E
SCHEMBL25848180 0.89 THRB (0.42) MAOBMAOANPC1RAB9AKDM4E
SCHEMBL22625318 0.89 MAOB (0.37) MAOBMAOANPC1RAB9AKDM4E
SCHEMBL25848187 0.89 MAOB (0.37) MAOBMAOANPC1RAB9AKDM4E
SCHEMBL22624946 0.86 MAOB (0.40) MAOBMAOANPC1RAB9AKDM4E
SCHEMBL22625294 0.85 MAOB (0.42) MAOBMAOANPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 MAOB 3207/4885MAOA 2922/4885NPC1 1051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.